Many drug companies rely heavily on the traditional markets in generating a() share of the market, desired market growth, leadership and profitability. The traditional markets exist on a free enterprise basis and their operations are regulated and controlled by the Bureau of Food and Drugs (BFAD) of the Department of Health (DOH). However, there are still instances when substandards, fake drug products or banned drugs exist and are readily available for the consuming public.